Get the latest research and practical clinical applications from the AUA 2024 Annual Meeting.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
2024
In-depth coverage of the 2024 EAU meeting
Coverage of the 2024 ASCO GU Symposium
Advertisement
2023
In-depth coverage of SUO 2023
Exclusive coverage from The Uromigos Live & Unplugged 2023
In-depth coverage of 2023 IKCS: North America
In-depth coverage of the ESMO 2023 Congress, featuring the latest research and science on urology.
In-depth coverage of the ESMO 2023 Congress, featuring the latest research and science on bladder cancer.
In-depth coverage of ASTRO 2023
In-depth coverage of the SNMMI 2023 Annual Meeting
In-depth coverage of the 2023 ASCO Annual Meeting
In-depth coverage of the AUA 2023 Annual Meeting, featuring the latest research and science on urology
In-depth coverage of the AUA 2023 Annual Meeting, featuring the latest research and science on bladder cancer
Coverage of the 2023 ASCO GU Symposium
2022
Kidney Cancer News and Research from 2022 IKCS: NORTH AMERICA
Prostate Cancer News and Research from SUO 2022
Prostate Cancer News and Research from the 2022 ASTRO Annual Meeting
Exclusive coverage from The Uromigos Live & Unplugged
Coverage of ESMO 2022
Coverage of the SNMMI 2022 Meeting
Coverage of the ASCO 2022 Annual Meeting
Coverage of AUA 2022
Coverage of the 2022 ASCO GU Symposium
2021
Coverage of AUA 2021
Coverage of the SUO Annual Meeting 2021
Coverage of the ASCO 2021 Annual Meeting
Coverage of the 2021 ASCO GU Symposium
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel shared their excitement for the road ahead in kidney cancer.
The panel addressed different dosing scenarios and shared tips on how to counsel patients on their treatment.
The panel shared their thoughts on quality of life data presented from the LITESPARK-005 trial of belzutifan.
The panel discussed the impact of a subcutaneous formulation of nivolumab.
The panel discussed the role of SBRT and some exciting studies like SAMURAI.
The panel discussed CheckMate 9ER, which assessed quality of life outcomes in patients receiving cabozantinib/nivolumab.
